Rituximab significantly improves complete response rate in patients with primary CNS lymphoma (Q47790904)
scientific article published on May 9, 2012
Language:
Current Data About Rituximab significantly improves complete response rate in patients with primary CNS lymphoma
(P31) (Q13442814)
(P248)
(P698) 22570142
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/22570142

(P50) (Q67209925)
(P1545) 4
(P1932) Andreas Straube
(P248)
(P698) 22570142
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/22570142

(P304) 285-291
(P248)
(P698) 22570142
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/22570142

(P407) (Q1860)
(P248)
(P698) 22570142
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22570142
(P813) Wednesday, January 1, 2025

(P433) 2
(P248)
(P698) 22570142
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/22570142

(P478) 109
(P248)
(P698) 22570142
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/22570142

(P577) Wednesday, May 9, 2012
(P248)
(P698) 22570142
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/22570142

(P921) (Q412323)
(P887)

(P953) http://link.springer.com/content/pdf/10.1007/s11060-012-0891-7.pdf
(P2701)
(P248)
(P356) 10.1007/S11060-012-0891-7
(P854) https://api.crossref.org/works/10.1007/S11060-012-0891-7
(P813) Wednesday, January 1, 2025

http://link.springer.com/article/10.1007/s11060-012-0891-7/fulltext.html
(P2701)
(P248)
(P356) 10.1007/S11060-012-0891-7
(P854) https://api.crossref.org/works/10.1007/S11060-012-0891-7
(P813) Wednesday, January 1, 2025

http://link.springer.com/content/pdf/10.1007/s11060-012-0891-7
(P248)
(P356) 10.1007/S11060-012-0891-7
(P854) https://api.crossref.org/works/10.1007/S11060-012-0891-7
(P813) Wednesday, January 1, 2025

(P1433) (Q15752119)
(P248)
(P698) 22570142
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/22570142

(P1476) "Rituximab significantly improves complete response rate in patients with primary CNS lymphoma" (language: en)
(P248)
(P698) 22570142
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/22570142

(P2093) Tobias Birnbaum
(P1545) 1
(P248)
(P698) 22570142
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/22570142

Elisabeth Anne Stadler
(P1545) 2
(P248)
(P698) 22570142
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/22570142

Louisa von Baumgarten
(P1545) 3
(P248)
(P698) 22570142
(P813) Monday, February 5, 2018
(P854) http://europepmc.org/abstract/MED/22570142

(P2860) (Q37484583)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS11060-012-0891-7
(P813) Sunday, January 21, 2018

(Q42849724)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS11060-012-0891-7
(P813) Sunday, January 21, 2018

(Q33381778)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS11060-012-0891-7
(P813) Sunday, January 21, 2018

(Q44642100)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS11060-012-0891-7
(P813) Sunday, January 21, 2018

(Q43864036)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS11060-012-0891-7
(P813) Sunday, January 21, 2018

(Q36163045)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS11060-012-0891-7
(P813) Sunday, January 21, 2018

(Q33377067)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS11060-012-0891-7
(P813) Sunday, January 21, 2018

(Q43506564)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS11060-012-0891-7
(P813) Sunday, January 21, 2018

(Q34132988)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS11060-012-0891-7
(P813) Sunday, January 21, 2018

(Q48874994)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS11060-012-0891-7
(P813) Sunday, January 21, 2018

(Q48364394)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS11060-012-0891-7
(P813) Sunday, January 21, 2018

(Q33906988)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS11060-012-0891-7
(P813) Sunday, January 21, 2018

(Q34686155)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS11060-012-0891-7
(P813) Sunday, January 21, 2018

(Q43274038)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS11060-012-0891-7
(P813) Sunday, January 21, 2018

(Q35783021)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS11060-012-0891-7
(P813) Sunday, January 21, 2018

(Q44858601)
(P248)
(P854) https://api.crossref.org/works/10.1007%2FS11060-012-0891-7
(P813) Sunday, January 21, 2018

(Q78409843)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/22570142
(P813) Saturday, December 12, 2020
(P887)

(Q83389320)
(P248)
(P854) https://pubmed.ncbi.nlm.nih.gov/22570142
(P813) Saturday, December 12, 2020
(P887)

other details
description scientific article published on May 9, 2012

External Links
(P356) 10.1007/S11060-012-0891-7
(P698) 22570142
(P5875) 224926047